Ayurcann Holdings Corp.
AYURF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 23.7% | 101.4% | 33.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 32.7% | 33.6% | 29.5% | 23.7% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -5.9% | -8% | -33.2% | -31.7% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -11.2% | -15.8% | -42.5% | -32.9% |
| EPS Diluted | -0.013 | -0.022 | -0.035 | -0.026 |
| % Growth | 41.5% | 36.7% | -35.6% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |